New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PetIQ, Inc.
PETQ
Shape
US Flag

NASDAQ

EPS improving

EPS improving

916M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Nov 2024

916M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Nov 2024

30.87USD
Shape-0.02 ( -0.06%)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated October 12, 2024
1W 0.00 % 1M 0.62 % 3M 39.56 % 1Y 50.44 %

Key Metrics

Shape
  • Market Cap

    915.91M


  • Shares Outstanding

    29.67M


  • Share in Float

    27.59M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    30.87


  • Average Volume

    853531


  • Beta

    1.736


  • Range

    15.09-31.06


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://petiq.com


  • Sector

    Healthcare


Fundamentals

Shape

19.54x

P/E Ratio

0.81x

P/S Ratio

3.54x

P/B Ratio

1.7

Debt/Equity

1.2%

Net Margin

$0.4

EPS

How PETQ compares to sector?

P/E Ratio

Relative Strength

Shape

PETQ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape270%

2025-Revenue

$1.86

Shape258%

2025-EPS

$71M

Shape96%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

William Blair

downgrade

Previous: Not converted

2024-08-07

Now: Market Perform

Benchmark

initialise

Previous: Not converted

2021-11-30

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+50%

0.15
vs 0.1

Q4.22

arrow
arrow

N/A

-0.10
vs -0.02

Q1.23

arrow
arrow

-27%

0.45
vs 0.62

Q2.23

arrow
arrow

-10%

0.46
vs 0.51

Q3.23

arrow
arrow

+180%

0.42
vs 0.15

Q4.23

arrow
arrow

N/A

-0.12
vs -0.10

Q1.24

arrow
arrow

+29%

0.58
vs 0.45

Q2.24

arrow
arrow

+52%

0.7
vs 0.46

Q3.24

arrow
arrow

-3%

0.41
vs 0.42

Q4.24

arrow
arrow

+111%

0.01
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

0%

209.7M  vs 210.5M

Q4.22

arrow
arrow

-6%

184.1M  vs 196.6M

Q1.23

arrow
arrow

+5%

290.5M  vs 275.7M

Q2.23

arrow
arrow

+25%

314.5M  vs 252M

Q3.23

arrow
arrow

+32%

277M  vs 209.7M

Q4.23

arrow
arrow

+19%

219.9M  vs 184.1M

Q1.24

arrow
arrow

+6%

308.4M  vs 290.5M

Q2.24

arrow
arrow

+5%

328.9M  vs 314.5M

Q3.24

arrow
arrow

+3%

286.6M  vs 277M

Q4.24

arrow
arrow

+5%

230.2M  vs 219.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-23%

-0.23
vs 0.02

Q4.22

arrow
arrow

-3%

-0.03
vs -0.23

Q1.23

arrow
arrow

+4%

0.04
vs -0.03

Q2.23

arrow
arrow

+4%

0.04
vs 0.04

Q3.23

arrow
arrow

+0%

0
vs 0.04

Q4.23

arrow
arrow

-8%

-0.08
vs 0

Q1.24

arrow
arrow

+6%

0.06
vs -0.08

Q2.24

arrow
arrow

+6%

0.06
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

151

151
vs 146

3%

Q4.22

arrow
arrow

157

157
vs 151

4%

Q1.23

arrow
arrow

150

150
vs 157

-4%

Q2.23

arrow
arrow

144

144
vs 150

-4%

Q3.23

arrow
arrow

166

166
vs 144

15%

Q4.23

arrow
arrow

172

172
vs 166

4%

Q1.24

arrow
arrow

175

175
vs 172

2%

Q2.24

arrow
arrow

187

187
vs 175

7%

Earnings Growth

Latest News